Clinical Trials Logo

Clinical Trial Summary

The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to describe the consequences of DISE in the therapeutic management for children with OSAHS. The secondary objectives were to analyze the correlation between the number of obstructive sites found during DISE, the value of apnea-hypopnea index (AHI), and the type of OSAHS.


Clinical Trial Description

Retrospective single center study of 31 children (mean age: 5.5 ± 2.6 years) who benefited from DISE between 2015 and 2018 in the management of OSAHS. Modification of therapeutic management was noted. A correlation between the number of obstructive sites and the IAH on the one hand, and between the number of obstructive sites and the type of SAHOS on the other hand, was sought. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03845062
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date October 1, 2015
Completion date August 1, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06460441 - Comparison of the SUNRISE© Device With Ventilatory Polygraphy for the Diagnosis of Obstructive Sleep Apnea Hypopnea Syndrome: Collection of Preliminary Data
Completed NCT03817762 - Feasibility in Every Day Pratice in an ENT Department and Value of the Automatic Detection of Respiratory Events